Skip To Main Content
R. Parrish Freeman on Muck Rack

R. Parrish Freeman

As seen in: Nature, Mondaq
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with R. Parrish

Contact R. Parrish, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson’s disease | Nature Aging

|
By M. Werner, A. McGarry, C. R. Meyer, E. Mancino, C. Klint, J. Gabriella Pellecchia, K. Kieburtz, T. Levine, B. Bellaire, C. Gibbons, R. Parrish Freeman, A. Ellenbogen, K. Klos, M. Ospina, R. Hauser, K. Shannon, H. Asaad, A. Park, P. McAllister, S. H. Isaacson, M. LeDoux, R. Dhall, D. Shpiner, P. Charles, P. K. Agarwal, E. Peckham, P. Mazzeo, M. M. Davis, R. Pahwa, M. Brodsky, M. Lew, L. Purino, S. Mantri, S. Parashos, W. Justiz, M. Chachar, B. Robottom, E. Budman, K. Blindauer, S. Bellows, J. Goudreau, S. Steen, C. W. Olanow
| Nature Verified
Abstract The nonreceptor Abelson (Abl) tyrosine kinases have been implicated as key drivers of initiation and progression in Parkinson’s disease (PD). Risvodetinib, a potent, brain-penetrant, selective inhibitor of the nonreceptor Abl kinases c-Abl1 and c-Abl2/Arg (collectively, c-Abl), was evaluated in a randomized, double-blind, placebo-controlled phase 2a trial (‘the 201 Trial’) using once-daily 50 mg, 100 mg, 200 mg or placebo in 137 participants with early, untreated PD.
Open in Who Shared Issue with article?

"Hey, That's My Idea!" Why Protecting Your Ideas Requires More Than Being First

|
By R. Parrish Freeman
| Mondaq
United States: "Hey, That's My Idea!" Why Protecting Your Ideas Requires More Than Being First 28 July 2021 by R. Parrish Freeman (Utah) Maschoff Brennan To print this article, all you need is to be registered or login on Mondaq.com. As the legendary racecar driver Ricky Bobby once said, "If you ain't first, you're last!" Couple of problems with that. First, Ricky Bobby doesn't exist, except in our hearts. Second, he's just wrong.
Open in Who Shared Issue with article?
See all 2 articles